FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

11429811000001104: Cabergoline 4mg tablets (Unichem Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41049001000001116 Cabergoline 4mg tablets (Unichem Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
41049101000001115 Cabergoline 4mg tablets (Unichem Plc) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
42074301000001119 Cabergoline 4mg tablets (UniChem Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
54560501000001111 Cabergoline 4mg tablets (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 4mg tablets (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Is a Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline 4mg tablets (Unichem Plc) 16 tablet Is pack of False Cabergoline 4mg tablets (Unichem Plc) Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Unichem Plc) 16 tablet Has AMP True Cabergoline 4mg tablets (Unichem Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start